A clinical trial to study effects of clopidogrel and newer antiplatelet agents ( Ticagrelor and Prasugrel) in patients with acute coronary syndrome who underwent PCI.
Not Applicable
- Conditions
- Health Condition 1: I249- Acute ischemic heart disease, unspecified
- Registration Number
- CTRI/2021/12/038560
- Lead Sponsor
- N Mehta institute of cardiology and research center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
ACS requiring early percutaneous
coronary intervention PCI within 72 h treatment with aspirin and a
newer P2Y12 blocker at discharge, no major adverse event one month
after the ACS and age greater than 18 years
Exclusion Criteria
history of intracranial
bleeding, contraindication to use of aspirin, clopidogrel, prasugrel,
or ticagrelor; major adverse event
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method